| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:05:18 UTC |
|---|
| Update date | 2024-11-29 22:27:53 UTC |
|---|
| Primary ID | FDB002250 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | L-Tryptophan |
|---|
| Description | L-Tryptophan, also known as Trp or W, belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. L-Tryptophan is a very strong basic compound (based on its pKa). L-Tryptophan exists in all living species, ranging from bacteria to humans. Within humans, L-tryptophan participates in a number of enzymatic reactions. In particular, L-tryptophan can be converted into n'-formylkynurenine through the action of the enzyme tryptophan 2,3-dioxygenase. In addition, L-tryptophan and tetrahydrobiopterin can be converted into 5-hydroxy-L-tryptophan and 4a-hydroxytetrahydrobiopterin through its interaction with the enzyme tryptophan 5-hydroxylase 1. The L-enantiomer of tryptophan. In humans, L-tryptophan is involved in tryptophan metabolism. Outside of the human body, L-Tryptophan is found, on average, in the highest concentration within a few different foods, such as caseins, steller sea lions, and evening primroses and in a lower concentration in thunnus, kefirs, and garden onions. L-Tryptophan has also been detected, but not quantified in, several different foods, such as thistles, gelatins, garden onion (var.), alpine sweetvetchs, and remoulades. This could make L-tryptophan a potential biomarker for the consumption of these foods. |
|---|
| CAS Number | 73-22-3 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (2S)-2-Amino-3-(1H-indol-3-yl)propanoic acid | ChEBI | | (S)-alpha-Amino-1H-indole-3-propanoic acid | ChEBI | | (S)-alpha-Amino-beta-(3-indolyl)-propionic acid | ChEBI | | (S)-Tryptophan | ChEBI | | L-(-)-Tryptophan | ChEBI | | L-beta-3-Indolylalanine | ChEBI | | Trp | ChEBI | | Tryptophan | ChEBI | | W | ChEBI | | (2S)-2-Amino-3-(1H-indol-3-yl)propanoate | Generator | | (S)-a-Amino-1H-indole-3-propanoate | Generator | | (S)-a-Amino-1H-indole-3-propanoic acid | Generator | | (S)-alpha-Amino-1H-indole-3-propanoate | Generator | | (S)-Α-amino-1H-indole-3-propanoate | Generator | | (S)-Α-amino-1H-indole-3-propanoic acid | Generator | | (S)-a-Amino-b-(3-indolyl)-propionate | Generator | | (S)-a-Amino-b-(3-indolyl)-propionic acid | Generator | | (S)-alpha-Amino-beta-(3-indolyl)-propionate | Generator | | (S)-Α-amino-β-(3-indolyl)-propionate | Generator | | (S)-Α-amino-β-(3-indolyl)-propionic acid | Generator | | L-b-3-Indolylalanine | Generator | | L-Β-3-indolylalanine | Generator | | (-)-Tryptophan | HMDB | | (L)-Tryptophan | HMDB | | (S)-1H-Indole-3-alanine | HMDB | | (S)-2-Amino-3-(3-indolyl)propionic acid | HMDB | | (S)-a-Amino-b-indolepropionate | HMDB | | (S)-a-Amino-b-indolepropionic acid | HMDB | | (S)-a-Aminoindole-3-propionate | HMDB | | (S)-a-Aminoindole-3-propionic acid | HMDB | | (S)-alpha-Amino-beta-indolepropionate | HMDB | | (S)-alpha-Amino-beta-indolepropionic acid | HMDB | | (S)-alpha-Aminoindole-3-propionate | HMDB | | (S)-alpha-Aminoindole-3-propionic acid | HMDB | | 1-beta-3-Indolylalanine | HMDB | | 1beta-3-Indolylalanine | HMDB | | 1H-Indole-3-alanine | HMDB | | 2-Amino-3-indolylpropanoate | HMDB | | 2-Amino-3-indolylpropanoic acid | HMDB | | 3-(1H-indol-3-yl)-L-Alanine | HMDB | | 3-indol-3-Ylalanine | HMDB | | Alpha'-amino-3-indolepropionic acid | HMDB | | alpha-Aminoindole-3-propionic acid | HMDB | | Ardeytropin | HMDB | | H-TRP-OH | HMDB | | Indole-3-alanine | HMDB | | Kalma | HMDB | | L-alpha-Amino-3-indolepropionic acid | HMDB | | L-alpha-Aminoindole-3-propionic acid | HMDB | | L-Tryptofan | HMDB | | L-Tryptophane | HMDB | | Lopac-T-0254 | HMDB | | Lyphan | HMDB | | Optimax | HMDB | | Pacitron | HMDB | | Sedanoct | HMDB | | Triptofano | HMDB | | Trofan | HMDB | | Tryptacin | HMDB | | Tryptan | HMDB | | Tryptophane | HMDB | | Tryptophanum | HMDB | | Ardeydorm | HMDB | | L Tryptophan | HMDB | | L-Tryptophan-ratiopharm | HMDB | | Merck brand OF tryptophan | HMDB | | Niddapharm brand OF tryptophan | HMDB | | ICN brand OF tryptophan | HMDB | | Levotryptophan | HMDB | | PMS Tryptophan | HMDB | | PMS-Tryptophan | HMDB | | Ratiopharm brand OF tryptophan | HMDB | | Esparma brand OF tryptophan | HMDB | | Ratio-tryptophan | HMDB | | L Tryptophan ratiopharm | HMDB | | Naturruhe | HMDB | | Tryptophan metabolism alterations | HMDB | | Ardeypharm brand OF tryptophan | HMDB | | Kalma brand OF tryptophan | HMDB | | Pharmascience brand OF tryptophan | HMDB | | Upsher-smith brand OF tryptophan | HMDB | | Ratio tryptophan | HMDB | | (S)-(-)-Tryptophan | biospider | | (S)-α-Amino-1H-indole-3-propanoic acid | biospider | | (S)-2-Amino-3-(1H-indol-3-yl)propanoic acid | biospider | | (S)-a-amino-b-(3-Indolyl)-propionate | Generator | | (S)-a-amino-b-(3-Indolyl)-propionic acid | Generator | | (S)-alpha-amino-beta-(3-Indolyl)-propionate | Generator | | (S)-Tryptophan 1H-Indole-3-alanine, (S)- | biospider | | (S)-α-amino-1H-indole-3-propanoate | Generator | | (S)-α-amino-1H-indole-3-propanoic acid | Generator | | (S)-α-amino-β-(3-indolyl)-propionate | Generator | | (S)-α-amino-β-(3-indolyl)-propionic acid | Generator | | 1H-Indole-3-alanine, (S)- | biospider | | 1H-Indole-3-propanoic acid, α-amino-, (S)- | biospider | | 1H-Indole-3-propanoic acid, alpha-amino-, (S)- | biospider | | 2-amino-3-Indolylpropanoate | HMDB | | 2-amino-3-Indolylpropanoic acid | HMDB | | alpha-Amino-3-indolepropionic acid, L- | biospider | | L-(-)-Tryptophane | biospider | | L-α-Amino-3-indolepropionic acid | biospider | | L-α-Aminoindole-3-propionic acid | biospider | | L-β-3-Indolylalanine | biospider | | L-a-Aminoindole-3-propionic acid | biospider | | L-Alanine, 3-(1H-indol-3-yl)- | biospider | | L-Tryptophan (9CI) | biospider | | L-β-3-indolylalanine | Generator | | Lopac-t-0254 | HMDB | | Tryptophan, 9CI, 8CI, USAN; L-form | db_source | | Tryptophan, L- (8CI) | biospider |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C11H12N2O2 |
|---|
| IUPAC name | (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid |
|---|
| InChI Identifier | InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1 |
|---|
| InChI Key | QIVBCDIJIAJPQS-VIFPVBQESA-N |
|---|
| Isomeric SMILES | N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O |
|---|
| Average Molecular Weight | 204.2252 |
|---|
| Monoisotopic Molecular Weight | 204.089877638 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as indolyl carboxylic acids and derivatives. Indolyl carboxylic acids and derivatives are compounds containing a carboxylic acid chain (of at least 2 carbon atoms) linked to an indole ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Indolyl carboxylic acids and derivatives |
|---|
| Direct Parent | Indolyl carboxylic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Indolyl carboxylic acid derivative
- Alpha-amino acid
- Alpha-amino acid or derivatives
- L-alpha-amino acid
- 3-alkylindole
- Indole
- Aralkylamine
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Pyrrole
- Amino acid or derivatives
- Amino acid
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Amine
- Primary aliphatic amine
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Indirect biological role: Industrial application: Biological role: |
|---|
| Foods | Dairy productsEggsMeats Grains: Nuts and legumes: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 64.69%; H 5.92%; N 13.72%; O 15.67% | DFC |
|---|
| Melting Point | Mp ca. 282° dec. | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 13.4 mg/mL at 25 oC | YALKOWSKY,SH & DANNENFELSER,RM (1992) |
|---|
| Experimental logP | -1.06 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | [a]21D -5.7 (5M HCl) | DFC |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| GC-MS | L-Tryptophan, 3 TMS, GC-MS Spectrum | splash10-0udi-0190000000-feaec8547634dddcad8c | Spectrum | | GC-MS | L-Tryptophan, 3 TMS, GC-MS Spectrum | splash10-0udi-0390000000-45a6c4fd79081597d44a | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0290000000-34f7274f31a4cb321a0b | Spectrum | | GC-MS | L-Tryptophan, 3 TMS, GC-MS Spectrum | splash10-0fk9-9270000000-9761607cbe821f87f172 | Spectrum | | GC-MS | L-Tryptophan, 1 TMS, GC-MS Spectrum | splash10-001i-0900000000-3faeed7ad32e1755c03c | Spectrum | | GC-MS | L-Tryptophan, 3 TMS, GC-MS Spectrum | splash10-0udi-0290000000-9c57a732e337fade3cb6 | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-001i-0900000000-d054a214c1717940989f | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0290000000-9860799c854e5c9ac1c7 | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0190000000-feaec8547634dddcad8c | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0390000000-45a6c4fd79081597d44a | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0290000000-34f7274f31a4cb321a0b | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-3729000000-86129db57aaf1a245f93 | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0fk9-9270000000-9761607cbe821f87f172 | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-001i-0900000000-3faeed7ad32e1755c03c | Spectrum | | GC-MS | L-Tryptophan, non-derivatized, GC-MS Spectrum | splash10-0udi-0290000000-9c57a732e337fade3cb6 | Spectrum | | Predicted GC-MS | L-Tryptophan, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0560-4900000000-fa932bc4cffed0ca66b7 | Spectrum | | Predicted GC-MS | L-Tryptophan, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00e9-9560000000-6829a8b2a2096883999f | Spectrum | | Predicted GC-MS | L-Tryptophan, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Tryptophan, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Tryptophan, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Tryptophan, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Tryptophan, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | L-Tryptophan, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-000i-0910000000-db5439a5499b19881720 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-014m-0900000000-cc4a579a29d19a1c0d44 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-00kf-3900000000-a931a9df4c855603d06e | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0a4i-0290000000-5fa576241f151a3a01a2 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0002-0900000000-417ea0b6e4e18e5fbde1 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-000i-0900000000-38f5ce97d594f3e3f12d | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-000i-0900000000-783ffff22f31096f238f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0a4i-0290000000-3ced9d310dda312f8582 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0002-0900000000-a050919a36b995d34553 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-000i-0900000000-1ddec73daead0ffadce4 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-000i-0900000000-a8c9c60f075a675f6629 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0udi-0290602010-c09c931538bff74ac400 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0a4i-0900000000-0fed327c2a56f556e04c | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0udi-0090000000-98ec1c2c012e58eab924 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-00di-0090000000-fc77784da5d9b288d751 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0udi-0290601010-d6f94902c0cf639cb7bc | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0a4i-0900000000-27633a4f7ecfac45c730 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-0udi-0090000000-ee6cb8392b2e8d644bc1 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative | splash10-004i-0090000000-d81c86eceee1c9824b02 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-0udi-0190000000-0e8b883dc8ab06c89d77 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-0uxu-2940000000-cb35b9680612e19d8b3a | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-014i-2900000000-7cc592351cc616b1d75f | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-014i-1900000000-987615a0add5eb2c3169 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-014i-1900000000-f150d9d1e19c72d337a8 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-0a4r-0690000000-ea2d79df0b56be85abdd | 2012-08-31 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 125 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 6066 |
|---|
| ChEMBL ID | CHEMBL54976 |
|---|
| KEGG Compound ID | C00078 |
|---|
| Pubchem Compound ID | 6305 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 16828 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00150 |
|---|
| HMDB ID | HMDB00929 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | CHP14-U:CHP19-Z |
|---|
| EAFUS ID | 3777 |
|---|
| Dr. Duke ID | L-TRYPTOPHAN|TRYPTOPHAN |
|---|
| BIGG ID | 33772 |
|---|
| KNApSAcK ID | C00001396 |
|---|
| HET ID | TRP |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Tryptophan |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Analgesic | 35480 | An agent that relieves pain by reducing or blocking pain signals in the brain, commonly used to manage acute or chronic pain, inflammation, and fever, with therapeutic applications in surgery, injury, and disease treatment. | DUKE | | Anti-anxiety | 52217 | An agent that reduces anxiety symptoms, commonly used in managing anxiety disorders, by modulating neurotransmitters such as GABA and serotonin, promoting relaxation and calming effects, with key medical uses including treatment of generalized anxiety, panic disorders, and social anxiety. | DUKE | | Anti-dementia | 52217 | An agent that slows or prevents cognitive decline, reducing symptoms of dementia. It plays a biological role in neuroprotection, enhancing neuronal function and survival. Therapeutically, it is used to manage Alzheimer's disease, vascular dementia, and other neurodegenerative disorders, improving memory, cognition, and daily functioning. | DUKE | | Anti depressant | 52217 | An agent that regulates mood, reducing symptoms of depression and anxiety by altering neurotransmitter levels in the brain, commonly used in managing depression, anxiety disorders, and other mood disorders. | DUKE | | Anti dyskinetic | | An agent that relieves or prevents dyskinesia, improving voluntary movement. It plays a biological role in regulating motor function, and has therapeutic applications in managing Parkinson's disease, Huntington's disease, and other movement disorders, reducing involuntary movements and improving motor control. | DUKE | | Anti hypertensive | 52217 | An agent that lowers blood pressure, reducing the risk of cardiovascular disease. It plays a biological role in relaxing blood vessels, decreasing cardiac workload, and improving blood flow. Therapeutically, it's used to manage hypertension, heart failure, and stroke, with key medical applications in preventing organ damage and improving overall cardiovascular health. | DUKE | | Anti-insomniac | 52217 | An agent that promotes sleep, reducing insomnia symptoms. It regulates the body's sleep-wake cycle, commonly used in managing sleep disorders, such as chronic insomnia, and improving overall sleep quality. | DUKE | | Anti-manic | | An agent that stabilizes mood by controlling symptoms of mania, used to manage bipolar disorder, reducing excessive excitement and impulsivity, and preventing manic episodes. | DUKE | | Anti-menopausal | 52217 | An agent that alleviates menopausal symptoms, regulating hormonal balance and reducing discomfort. Therapeutically, it is used to manage hot flashes, night sweats, and mood changes, improving quality of life for menopausal women. Key medical uses include hormone replacement therapy and treatment of menopause-related disorders. | DUKE | | Anti-migraine | 52217 | An agent that alleviates migraine symptoms, commonly used to treat and prevent migraine headaches by constricting blood vessels and blocking pain pathways, providing relief from severe headaches, nausea, and sensitivity to light and sound. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-Parkinsonian | 48407 | An agent that alleviates symptoms of Parkinson's disease, enhancing dopamine levels and improving motor function, commonly used to manage tremors, rigidity, and bradykinesia in neurodegenerative disorders. | DUKE | | Anti phenylketonuric | 52217 | An agent that reduces phenylalanine levels, managing phenylketonuria (PKU) by inhibiting enzymes involved in phenylalanine metabolism, thereby preventing intellectual disability and other complications associated with the condition. | DUKE | | Anti prostaglandin | 49020 | An agent that inhibits prostaglandin production, reducing inflammation and pain. Therapeutically, it's used to treat conditions like arthritis, menstrual cramps, and post-surgical pain, by blocking prostaglandin-mediated responses, providing relief from inflammation and discomfort. | DUKE | | Anti psychotic | 35476 | An agent that reduces psychotic symptoms, commonly used in managing schizophrenia, bipolar disorder, and other mental health conditions by blocking dopamine receptors in the brain, thereby alleviating hallucinations, delusions, and disordered thinking. | DUKE | | Anti-rheumatic | 52217 | An agent that reduces inflammation and alleviates symptoms of rheumatic diseases, such as arthritis. It plays a biological role in modulating the immune system and inhibiting pro-inflammatory pathways. Therapeutically, anti-rheumatics are used to manage conditions like rheumatoid arthritis, lupus, and osteoarthritis, reducing pain, swelling, and joint damage. Key medical uses include slowing disease progression and improving quality of life for patients with chronic rheumatic conditions. | DUKE | | Anti-scoliotic | 52217 | An agent that prevents or reduces the progression of scoliosis, a lateral curvature of the spine. It plays a biological role in maintaining spinal alignment and stability. Therapeutically, it is used to manage scoliosis, particularly in children and adolescents, to prevent deformity and promote proper spinal growth, reducing the need for surgical intervention. | DUKE | | Carcinogenic | 50903 | An agent that causes cancer, damaging cellular DNA and disrupting normal cell growth. It has no therapeutic applications, but understanding its biological role informs cancer prevention and treatment strategies, with key medical uses in oncology research and risk assessment. | DUKE | | Essential | | A substance crucial for a specific biological process or condition, playing a vital role in maintaining health. Therapeutically, essentials are used to prevent or treat deficiencies, with key medical applications including nutrition, hormone regulation, and disease prevention, ultimately supporting overall well-being. | DUKE | | Hypnotic | | An agent that induces sleep, used to treat insomnia and facilitate surgical anesthesia, playing a key role in regulating sleep patterns and providing therapeutic relief for sleep disorders. | DUKE | | Hypoglycemic | 35526 | An agent that lowers blood glucose levels, playing a crucial role in glucose metabolism. Therapeutically, it is used to manage diabetes and insulin resistance, with key medical applications in treating type 1 and 2 diabetes, and preventing diabetic complications. | DUKE | | Hypotensive | | An agent that lowers blood pressure, playing a biological role in regulating cardiovascular function. Therapeutically, it's used to manage hypertension, heart failure, and angina, with key medical applications in preventing stroke, kidney disease, and cardiac complications. | DUKE | | Insulinase inhibitor | 23924 | An agent that blocks the activity of insulinase, an enzyme that breaks down insulin, thereby increasing insulin levels and activity. It has therapeutic applications in managing diabetes and improving glucose metabolism, with key medical uses in treating type 1 and 2 diabetes. | DUKE | | Insulinotonic | | An agent that enhances insulin secretion, improving glucose uptake and utilization. It plays a biological role in regulating blood sugar levels. Therapeutically, insulinotonic agents are used to manage type 2 diabetes, increasing insulin sensitivity and reducing glucose production in the liver, thereby lowering blood glucose levels. | DUKE | | Monoamine precursor | | An amino acid (e.g., phenylalanine, tyrosine, tryptophan) that serves as a building block for monoamine neurotransmitters like serotonin, norepinephrine, and dopamine, playing a crucial role in mood regulation and therapeutic applications in managing depression, anxiety, and other neurological disorders. | DUKE | | Prolactinogenic | | An agent that stimulates the production of prolactin, a hormone involved in lactation and breast development, with potential therapeutic applications in treating infertility and lactation disorders, and key medical uses in inducing milk production and managing hormonal imbalances. | DUKE | | Sedative | 35717 | An agent that calms nervous activity, reducing anxiety and inducing relaxation. Its biological role is to slow down brain function, promoting sleep and relieving stress. Therapeutically, sedatives are used to manage insomnia, anxiety disorders, and seizures, as well as to prepare patients for medical procedures. | DUKE | | Serotoninergic | 48278 | An agent that modulates serotonin activity, regulating mood, appetite, and sleep. It has therapeutic applications in treating depression, anxiety, and mood disorders, with key medical uses including antidepressants, anxiolytics, and anti-migraine medications. | DUKE | | Tumor promoter | 50903 | A substance that enhances the growth and proliferation of cancer cells, often used in research to study cancer development. Therapeutically, understanding tumor promoters informs cancer prevention and treatment strategies, with applications in oncology for developing targeted therapies to inhibit tumor growth and progression. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Aromatic-L-amino-acid decarboxylase | DDC | P20711 | | Tryptophan 5-hydroxylase 1 | TPH1 | P17752 | | Tryptophan 5-hydroxylase 2 | TPH2 | Q8IWU9 | | Tryptophan--tRNA ligase, cytoplasmic | WARS | P23381 | | Tryptophan--tRNA ligase, mitochondrial | WARS2 | Q9UGM6 |
|
|---|
| Pathways | | Name | SMPDB Link | KEGG Link |
|---|
| Transcription/Translation | SMP00019 | Not Available | | Tryptophan Metabolism | SMP00063 | map00380 | | Metabolism and Physiological Effects of Indole Acetic Acid | SMP0123235 | Not Available | | Metabolism and Physiological Effects of Indoxyl Sulfate | SMP0123237 | Not Available | | Metabolism and Physiological Effects of Indoxyl glucuronide | SMP0123239 | Not Available | | Metabolism and Physiological Effects of Quinolinic Acid | SMP0123249 | Not Available | | Metabolism and Physiological Effects of Kynurenic Acid | SMP0123300 | Not Available | | Metabolism and Physiological Effects of Indoxyl glucoside (indican) | SMP0124742 | Not Available | | Metabolism and Physiological Effects of Kynurenine | SMP0125524 | Not Available | | Metabolism and Physiological Effects of N-Acetyltryptophan | SMP0126721 | Not Available | | Metabolism and Physiological Effects of Indolelactic Acid | SMP0126749 | Not Available | | Metabolism and Physiological Effects of Indolelacetyl glutamine | SMP0126755 | Not Available | | Metabolism and Physiological Effects of 2-Aminobenzoic acid | SMP0126869 | Not Available |
|
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Saxholt, E., et al. 'Danish food composition databank, revision 7.' Department of Nutrition, National Food Institute, Technical University of Denmark (2008). — U.S. Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|